ANXA6 and cancer: It is also possible that the relatively modest EGFR prognostic value in some cancers including breast cancer, may be due to the modulation of its cellular levels and activity by amongst other cellular factors scaffolding proteins such as MUC4 [16] and AnxA6 [17-20].